Kallikrein inhibitors decrease short-circuit current by inhibiting sodium uptake.
D000590:Amino Acid Chloromethyl Ketones / Q000494:pharmacology; D000666:Amphotericin B / Q000494:pharmacology; D000818:Animals; D007611:Aprotinin / Q000494:pharmacology; D002024:Bufo marinus; D004560:Electricity; D005260:Female; D007610:Kallikreins / Q000037:antagonists & inhibitors*; D009092:Mucous Membrane / Q000187:drug effects; D010042:Ouabain / Q000494:pharmacology; D012964:Sodium / Q000378:metabolism*; D001743:Urinary Bladder / Q000187:drug effects
D000590:Amino Acid Chloromethyl Ketones; D010042:Ouabain; C027587:phenylalanyl-phenylalanyl-arginine chloromethyl ketone; D000666:Amphotericin B; D007611:Aprotinin; D012964:Sodium; D007610:Kallikreins